Literature DB >> 18852539

Diabetes and osteoporosis.

Alois Saller1, Stefania Maggi, Giovanna Romanato, Paolo Tonin, Gaetano Crepaldi.   

Abstract

Care of patients with diabetes should include assessment of bone health. The extension of the average life expectancy of people with diabetes, which has accompanied improvements in medical care, has also increased the significance of osteoporosis. In addition to the usual causes of osteoporosis associated with aging, bone health is also compromised by diabetes. Studies on bone involvement in patients with diabetes mellitus have generated conflicting results, largely because of the pathogenetic complexity of the condition. It is now clear that patients with type 1 diabetes have lower bone mineral density (BMD) and a higher risk of fractures. Evidence is emerging that patients with type 2 diabetes who have complications are also at increased risk of certain types of osteoporotic fractures, despite having a higher BMD when compared to patients with type 1 diabetes. Although many factors, including number and type of falls, visual impairment, neuropathy, and reduced muscle strength, influence the probability of fractures, the most significant factor seems to be the strength of the bone itself. Thus, sarcopenia, a reduction in muscle mass and muscle strength, is considered one of the main determinants of bone fragility. The aim of this review is to examine the occurrence of osteoporosis in type 1 and type 2 diabetes.

Entities:  

Mesh:

Year:  2008        PMID: 18852539     DOI: 10.1007/bf03324857

Source DB:  PubMed          Journal:  Aging Clin Exp Res        ISSN: 1594-0667            Impact factor:   3.636


  14 in total

1.  Association between bone mineral density and type 2 diabetes mellitus: a meta-analysis of observational studies.

Authors:  Lili Ma; Ling Oei; Lindi Jiang; Karol Estrada; Huiyong Chen; Zhen Wang; Qiang Yu; Maria Carola Zillikens; Xin Gao; Fernando Rivadeneira
Journal:  Eur J Epidemiol       Date:  2012-03-27       Impact factor: 8.082

2.  Alteration of vitamin D metabolic enzyme expression and calcium transporter abundance in kidney involved in type 1 diabetes-induced bone loss.

Authors:  Y Zhang; C J Papasian; H-W Deng
Journal:  Osteoporos Int       Date:  2010-09-29       Impact factor: 4.507

3.  The Effects of Soy Milk Enriched with Lactobacillus casei and Omega-3 on the Tibia and L5 Vertebra in Diabetic Rats: a Stereological Study.

Authors:  Maryam Bayat; Mohammad Hossein Dabbaghmanesh; Farhad Koohpeyma; Marzieh Mahmoodi; Nima Montazeri-Najafabady; Marzieh Bakhshayeshkaram
Journal:  Probiotics Antimicrob Proteins       Date:  2019-12       Impact factor: 4.609

4.  Diabetes reduces mesenchymal stem cells in fracture healing through a TNFα-mediated mechanism.

Authors:  Kang I Ko; Leila S Coimbra; Chen Tian; Jazia Alblowi; Rayyan A Kayal; Thomas A Einhorn; Louis C Gerstenfeld; Robert J Pignolo; Dana T Graves
Journal:  Diabetologia       Date:  2015-01-07       Impact factor: 10.122

5.  Increasing fasting glucose and fasting insulin associated with elevated bone mineral density-evidence from cross-sectional and MR studies.

Authors:  H Zhou; C Li; W Song; M Wei; Y Cui; Q Huang; Q Wang
Journal:  Osteoporos Int       Date:  2021-01-06       Impact factor: 4.507

6.  Imaging of diabetic bone.

Authors:  Federico Ponti; Sara Guerri; Claudia Sassi; Giuseppe Battista; Giuseppe Guglielmi; Alberto Bazzocchi
Journal:  Endocrine       Date:  2017-03-14       Impact factor: 3.633

7.  Insulin receptor substrate 2 plays important roles in 17beta-estradiol-induced bone formation.

Authors:  Y-H Bu; D Peng; H-D Zhou; Q-X Huang; W Liu; X-B Luo; L-L Tang; A-G Tang
Journal:  J Endocrinol Invest       Date:  2009-05-26       Impact factor: 4.256

8.  EFFECT OF PUERARIN ON THE PROLIFERATION AND DIFFERENTIATION OF OSTEOBLASTS AND THE EXPRESSION OF TYPE I COLLAGEN mRNA IN A HIGH-GLUCOSE ENVIRONMENT.

Authors:  X H Wang; X W Shi; X X Luo; D H Zhang
Journal:  Acta Endocrinol (Buchar)       Date:  2020 Jul-Sep       Impact factor: 0.877

9.  Association between osteoprotegerin G1181C and T245G polymorphisms and diabetic charcot neuroarthropathy: a case-control study.

Authors:  Dario Pitocco; Giovanni Zelano; Giuseppina Gioffrè; Enrico Di Stasio; Francesco Zaccardi; Francesca Martini; Tittania Musella; Giuseppe Scavone; Marco Galli; Salvatore Caputo; Lorena Mancini; Giovanni Ghirlanda
Journal:  Diabetes Care       Date:  2009-06-05       Impact factor: 19.112

10.  Prevalence of Osteoporosis and Its Associated Factors among Older Men with Type 2 Diabetes.

Authors:  Hai-Ling Chen; Li-Li Deng; Ju-Fen Li
Journal:  Int J Endocrinol       Date:  2013-01-17       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.